Additionally, eosinophils are capable of remodelling the TME by expressing natural killer (NK)-cell-associated activation receptors, such as 2B4, NKG2D and LY49, and promoting anti-tumor immunity through release of IFNγ. The gene discussed is CD244; the disease is neoplasm.